By Elina Sabilova, Billing Department, WCH
Cardiology has always been a procedurally intensive specialty. Catheterizations, ablations, device implants, stress tests — high-volume, high-complexity work with correspondingly high CPT-based reimbursement. That transactional clarity made cardiology one of the most financially productive specialties in American medicine.
That clarity is eroding.
What is replacing it is not a refined version of fee-for-service. It is a structurally different revenue architecture — one where the unit of financial accountability is not the procedure performed, but the outcome sustained over time.
1. The Regulatory Trajectory Is Not Ambiguous
The direction of CMS policy in cardiology is explicit and accelerating.
By 2030, CMS has committed to tying every Medicare dollar to a value-based payment model. That target was articulated at ACC.24 by Stanford cardiologist Alex Sandhu, MD, and it represents a system-wide deadline — not a pilot program.
The architecture of that shift is already visible:
MIPS (Merit-based Incentive Payment System) currently adjusts cardiology reimbursement across four weighted categories: Quality, Cost, Improvement Activities, and Promoting Interoperability. Payment adjustments — positive and negative — compound over time. Practices that treat MIPS as a compliance exercise rather than a revenue management system are leaving measurable income on the table.
ACO REACH ties financial settlement directly to quality performance. In PY 2025, CMS withholds 2% of a REACH ACO’s entire financial benchmark, releasing it based on performance across all-condition readmission rates, unplanned admissions in patients with multiple chronic conditions, and timely follow-up metrics.
The Ambulatory Specialty Model (ASM), set to launch in 2027 as a mandatory CMS program, will directly target cardiology. Cardiologists managing chronic heart failure will face outcome-based reimbursement tied to 30-day readmission rates, ejection fraction improvement documentation, medication management adherence, and care coordination metrics. Unlike MIPS, which is voluntary and general, ASM is specialty-specific and mandatory.
The procedural CPT code is not disappearing. But it is no longer sufficient as a revenue strategy.
2. The Economic Inversion: From Transactional to Longitudinal
Under fee-for-service, cardiology revenue is event-based:
Procedure performed → CPT code captured → claim submitted → reimbursement received
Under value-based models, revenue becomes longitudinal:
Population managed → outcomes tracked → cost benchmarks met → financial reconciliation
This inversion has concrete consequences:
Volume no longer guarantees revenue. A cardiologist who performs more procedures but generates higher downstream costs — through readmissions, avoidable hospitalizations, or suboptimal chronic disease management — will see revenue erode under risk-sharing contracts.
The 30-day window is a financial instrument. Heart failure readmissions exceed 40% nationally within 90 days of discharge. Under bundled and ACO payment models, each readmission is not a separate billing event — it is a cost overrun that reduces the shared savings available to the practice.
Chronic disease management is now revenue-generating infrastructure. Under longitudinal models, the cardiologist who keeps the heart failure patient stable and out of the hospital is not just delivering good care — they are protecting margin. When cardiologists participate in MSSP ACOs, spending on cardiovascular beneficiaries is approximately $200 lower per patient per year compared to non-participating peers, with equivalent quality outcomes.
3. The KPI Stack That Now Drives Cardiology Income
Legacy metrics — procedures per week, RVUs, denial rates — remain necessary but no longer sufficient. The modern cardiology revenue stack is defined by six variables:
30-Day Readmission Rate — the single most financially consequential metric under both CMS penalty programs and ACO reconciliation logic. It is measurable, improvable, and directly tied to reimbursement in nearly every value-based model.
MIPS Composite Score — determines annual payment adjustments across all Medicare claims. A low MIPS score compounds into revenue loss over time; a high score creates a sustainable upward adjustment.
Guideline-Directed Medical Therapy (GDMT) Adherence — under ASM and emerging heart failure payment models, adherence to evidence-based protocols (beta-blockers, ACE inhibitors, ARNI therapy) is both a quality measure and a reimbursement input.
Total Cost of Care per Beneficiary — under ACO structures, spending per attributed patient is reconciled against benchmarks. High-cost outliers reduce shared savings across the entire attributed population.
Patient-Reported Outcomes — increasingly required for quality measure reporting, and increasingly used as contracting leverage with commercial payers. Practices that systematically capture and document functional outcomes have a measurable advantage in payer negotiations.
Post-Discharge Follow-Up Timeliness — a direct quality measure in ACO REACH and a predictive indicator for readmission reduction. Early follow-up within 7–14 days post-discharge is consistently associated with lower rehospitalization rates in heart failure populations.
4. The Infrastructure Problem Most Practices Are Not Solving
The clinical knowledge required to succeed in value-based cardiology exists. Most cardiologists understand the evidence base. The constraint is not clinical — it is operational.
Value-based performance is measured longitudinally, across settings, and reconciled retrospectively by payers. That process requires: episode-level cost visibility, outcome data capture integrated into clinical workflow, real-time MIPS tracking, and revenue cycle systems capable of translating performance data into accurate financial reporting.
Most cardiology practices are still operating with billing infrastructure designed for transactional FFS logic. That infrastructure cannot see what it cannot measure — and what it cannot measure is where value-based revenue is won or lost.
WCH Service Bureau has supported healthcare providers for over 25 years, offering medical billing, credentialing, chart auditing, and practice management as an integrated system. As the cardiology revenue landscape continues to evolve, we are here to help your practice navigate the transition and protect your financial performance.
Learn more at wchsb.com
Sources
- Sandhu A. How the shift to value-based reimbursements could transform cardiology. Cardiovascular Business. May 2024. cardiovascularbusiness.com
- Wasfy J. Value-based care gives cardiology practices an opportunity to thrive. Cardiovascular Business / Heart Rhythm 2024. cardiovascularbusiness.com
- Sukul D, Eagle KA. Value-Based Payment Reforms in Cardiovascular Care: Progress to Date and Next Steps. Methodist Debakey Cardiovasc J. 2020;16(3):232–240. PMC7587316
- CMS. ACO REACH Model PY 2025 Quality Measurement Methodology Report. cms.gov. May 2025.
- CMS QPP. Advancing Care for Heart Disease MVP — 2025 Performance Year. qpp.cms.gov
- Heidenreich PA et al. Advancing Value-Based Models for Heart Failure. Circ Cardiovasc Qual Outcomes. 2020. doi: 10.1161/CIRCOUTCOMES.120.006483
- Yancy CW et al. 2020 ACC/AHA Clinical Performance and Quality Measures for Adults With Heart Failure. Circ Cardiovasc Qual Outcomes. 2020. doi: 10.1161/HCQ.0000000000000099
- CloudRCM Solutions. CMS Ambulatory Specialty Model (ASM) 2027. cloudrcmsolutions.com. November 2025.
- OmniMD. The Shift to Value-Based Care in Cardiology. omnimd.com. October 2025.
- MDinteractive. 2025 MIPS Measures Relevant to Cardiology. mdinteractive.com. 2025.
Discover more from Doctor Trusted
Subscribe to get the latest posts sent to your email.
